HUMAW - Humacyte outlines expansion of Symvess to 45 hospitals while targeting BLA submission for ATEV in dialysis by 2026
2025-05-13 14:29:50 ET
More on Humacyte, Humacyte, Inc. WT EXP, etc.
- Humacyte, Inc. (HUMA) Q1 2025 Earnings Call Transcript
- Humacyte, Inc. (HUMA) Q4 2024 Earnings Conference Call Transcript
- Humacyte: Doubts Cast Around Efficacy Of Symvess May Be Hard To Dispel
- Humacyte GAAP EPS of $0.28 beats by $0.47, revenue of $0.52M misses by $0.24M
- Humacyte Q1 2025 Earnings Preview